Metropolitan Life Insurance Company (MetLife)’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,651
| Closed | -$61.1K | – | 2364 |
|
|
2022
Q3 | $61.1K | Hold |
1,651
| – | – | ﹤0.01% | 1322 |
|
|
2022
Q2 | $31.4K | Hold |
1,651
| – | – | ﹤0.01% | 1790 |
|
|
2022
Q1 | $44.6K | Sell |
1,651
-3,013
| -65% | -$81.3K | ﹤0.01% | 1663 |
|
|
2021
Q4 | $105K | Hold |
4,664
| – | – | ﹤0.01% | 2448 |
|
|
2021
Q3 | $122K | Hold |
4,664
| – | – | ﹤0.01% | 2413 |
|
|
2021
Q2 | $149K | Hold |
4,664
| – | – | ﹤0.01% | 2367 |
|
|
2021
Q1 | $164K | Hold |
4,664
| – | – | ﹤0.01% | 2156 |
|
|
2020
Q4 | $150K | Hold |
4,664
| – | – | ﹤0.01% | 2134 |
|
|
2020
Q3 | $175K | Hold |
4,664
| – | – | ﹤0.01% | 1852 |
|
|
2020
Q2 | $209K | Buy |
+4,664
| New | +$209K | ﹤0.01% | 1764 |
|